IL132903A0 - N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists - Google Patents

N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists

Info

Publication number
IL132903A0
IL132903A0 IL13290398A IL13290398A IL132903A0 IL 132903 A0 IL132903 A0 IL 132903A0 IL 13290398 A IL13290398 A IL 13290398A IL 13290398 A IL13290398 A IL 13290398A IL 132903 A0 IL132903 A0 IL 132903A0
Authority
IL
Israel
Prior art keywords
indolecarboxamides
cck
triazolyl
agonists
Prior art date
Application number
IL13290398A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL132903A0 publication Critical patent/IL132903A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IL13290398A 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists IL132903A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1998/000905 WO1998051686A1 (fr) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a

Publications (1)

Publication Number Publication Date
IL132903A0 true IL132903A0 (en) 2001-03-19

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13290398A IL132903A0 (en) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists

Country Status (35)

Country Link
EP (1) EP0984960B1 (de)
JP (1) JP2001524980A (de)
KR (1) KR20010012541A (de)
CN (1) CN1263528A (de)
AR (1) AR011729A1 (de)
AT (1) ATE232207T1 (de)
AU (1) AU725530B2 (de)
BR (1) BR9811465A (de)
CA (1) CA2289573A1 (de)
CO (1) CO4940485A1 (de)
CZ (1) CZ289484B6 (de)
DE (1) DE69811223T2 (de)
DK (1) DK0984960T3 (de)
DZ (1) DZ2486A1 (de)
EE (1) EE9900524A (de)
ES (1) ES2190081T3 (de)
FR (1) FR2763337B1 (de)
GT (1) GT199800068A (de)
HR (1) HRP980258B1 (de)
HU (1) HUP0002763A3 (de)
ID (1) ID22911A (de)
IL (1) IL132903A0 (de)
IS (1) IS5235A (de)
NO (1) NO995513L (de)
NZ (1) NZ500637A (de)
PL (1) PL336772A1 (de)
RU (1) RU2175323C2 (de)
SI (1) SI0984960T1 (de)
SK (1) SK154299A3 (de)
TR (1) TR199902795T2 (de)
TW (1) TW396155B (de)
UY (1) UY24997A1 (de)
WO (1) WO1998051686A1 (de)
YU (1) YU57999A (de)
ZA (1) ZA983997B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
US20040019091A1 (en) * 2000-10-26 2004-01-29 Eric Bignon Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
ES2256560T3 (es) * 2001-10-12 2006-07-16 Bayer Pharmaceuticals Corporation Heterociclos de 5 mienbros que contienen nitrogeno sustituidos con felino para el tratamiento de la obesidad.
EP1314733A1 (de) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indol-2-carbonsäureamide als Faktor-Xa-Hemmer
EP1479677A1 (de) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Neue Indolderivate als Faktor Xa-Inhibitoren
EP1532980A1 (de) * 2003-11-24 2005-05-25 Novo Nordisk A/S N-Heteroaryl Indol-Carboxamide und deren analoga zur Vewendung als glucokinase Aktivatoren zur Behandlung von Diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
ATE528006T1 (de) * 2007-01-26 2011-10-15 Merck Sharp & Dohme Substituierte aminopyrimidine als cholecystokinin-1-rezeptormodulatoren
CA2731097A1 (en) * 2008-07-15 2010-01-21 Novartis Ag Organic compounds
CN102414207B (zh) * 2009-06-09 2015-09-30 埃科特莱茵药品有限公司 氟化氨基三唑衍生物
EP2490656B1 (de) * 2009-10-22 2017-01-18 Henkel AG & Co. KGaA Mittel zur behandlung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein anionisches polymer
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
SK154299A3 (en) 2000-05-16
YU57999A (sh) 2002-06-19
EE9900524A (et) 2000-06-15
RU2175323C2 (ru) 2001-10-27
AU725530B2 (en) 2000-10-12
NO995513L (no) 2000-01-12
ID22911A (id) 1999-12-16
DE69811223D1 (de) 2003-03-13
NO995513D0 (no) 1999-11-11
EP0984960A1 (de) 2000-03-15
DE69811223T2 (de) 2003-11-27
NZ500637A (en) 2000-11-24
SI0984960T1 (en) 2003-06-30
EP0984960B1 (de) 2003-02-05
PL336772A1 (en) 2000-07-17
HUP0002763A3 (en) 2002-05-28
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
ES2190081T3 (es) 2003-07-16
DK0984960T3 (da) 2003-05-26
CZ400699A3 (cs) 2000-02-16
TR199902795T2 (xx) 2000-02-21
IS5235A (is) 1999-10-29
FR2763337A1 (fr) 1998-11-20
TW396155B (en) 2000-07-01
CZ289484B6 (cs) 2002-01-16
AR011729A1 (es) 2000-08-30
BR9811465A (pt) 2000-09-12
DZ2486A1 (fr) 2003-02-01
HUP0002763A2 (hu) 2001-06-28
KR20010012541A (ko) 2001-02-15
HRP980258B1 (en) 2002-08-31
WO1998051686A1 (fr) 1998-11-19
ATE232207T1 (de) 2003-02-15
UY24997A1 (es) 2000-10-31
FR2763337B1 (fr) 1999-08-20
ZA983997B (en) 1999-11-12
CO4940485A1 (es) 2000-07-24
CN1263528A (zh) 2000-08-16
JP2001524980A (ja) 2001-12-04
GT199800068A (es) 1999-11-11
HRP980258A2 (en) 1999-02-28

Similar Documents

Publication Publication Date Title
ZA9711141B (en) Novel ketobenzamides and their use
EP1032377A4 (de) Substituierte 2-aminoacetamide und anwendung davon
GB9813271D0 (en) Composition and use
ZA200101933B (en) Novel composition and use
ZA985096B (en) Composition compound and use
HK1033653A1 (en) Synergistic composition and use thereof
GB9717598D0 (en) Novel composition and use
IL132903A0 (en) N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists
GB9702354D0 (en) Compounds and their use
GB9811168D0 (en) Direct hair-colouring compositions and the use thereof
GB2367749B (en) Depilatory compositions and their use
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
IL123535A0 (en) Benzoxazindione derivatives and their use
GB9622905D0 (en) Dispersing agents and their use
GB9718636D0 (en) Novel composition and use
EP0998578A4 (de) Sel-10 und dessen verwendungen
PL341293A1 (en) Beta-lypothropin and application thereof
GB9722392D0 (en) Composition and use
GB9413076D0 (en) Composition and use
GB9805172D0 (en) Composition and use
GB9722390D0 (en) Composition and use
GB9712961D0 (en) Composition and use
GB9716805D0 (en) Novel composition and use
GB9719203D0 (en) Novel composition and use
GB9715323D0 (en) Piperidinecarboxamides and their use